These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26455408)

  • 1. Cell Biology of Prions and Prionoids: A Status Report.
    Aguzzi A; Lakkaraju AKK
    Trends Cell Biol; 2016 Jan; 26(1):40-51. PubMed ID: 26455408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prions, prionoids and protein misfolding disorders.
    Scheckel C; Aguzzi A
    Nat Rev Genet; 2018 Jul; 19(7):405-418. PubMed ID: 29713012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion-like features of misfolded Aβ and tau aggregates.
    Morales R; Callegari K; Soto C
    Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion, prionoids and infectious amyloid.
    Liberski PP
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S80-4. PubMed ID: 24262195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion-Like Protein Aggregates and Type 2 Diabetes.
    Mukherjee A; Soto C
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcellular spread of cytosolic amyloids, prions, and prionoids.
    Aguzzi A; Rajendran L
    Neuron; 2009 Dec; 64(6):783-90. PubMed ID: 20064386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions: a model of conformational disease?
    Morinet F
    Pathol Biol (Paris); 2014 Apr; 62(2):96-9. PubMed ID: 24656441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes as a protein misfolding disease.
    Mukherjee A; Morales-Scheihing D; Butler PC; Soto C
    Trends Mol Med; 2015 Jul; 21(7):439-49. PubMed ID: 25998900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ seeds and prions: How close the fit?
    Rasmussen J; Jucker M; Walker LC
    Prion; 2017 Jul; 11(4):215-225. PubMed ID: 28657440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for prion-like diseases.
    Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
    Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From soluble aβ to progressive aβ aggregation: could prion-like templated misfolding play a role?
    Eisele YS
    Brain Pathol; 2013 May; 23(3):333-41. PubMed ID: 23587139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.
    Eraña H; Charco JM; Di Bari MA; Díaz-Domínguez CM; López-Moreno R; Vidal E; González-Miranda E; Pérez-Castro MA; García-Martínez S; Bravo S; Fernández-Borges N; Geijo M; D'Agostino C; Garrido J; Bian J; König A; Uluca-Yazgi B; Sabate R; Khaychuk V; Vanni I; Telling GC; Heise H; Nonno R; Requena JR; Castilla J
    PLoS Pathog; 2019 Oct; 15(10):e1008117. PubMed ID: 31644574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein misfolding and aggregation by natural phenolic compounds.
    Dhouafli Z; Cuanalo-Contreras K; Hayouni EA; Mays CE; Soto C; Moreno-Gonzalez I
    Cell Mol Life Sci; 2018 Oct; 75(19):3521-3538. PubMed ID: 30030591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
    Jaunmuktane Z; Brandner S
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
    Ries HM; Nussbaum-Krammer C
    Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.